"Manganese-induced neurotoxicity: A review of its behavioral consequences and neuroprotective strategies"

Tanara V. Peres, Maria Rosa C Schettinger, Pan Chen, Fabiano Carvalho, Daiana S. Avila, Aaron B. Bowman, Michael Aschner

Research output: Contribution to journalReview article

75 Citations (Scopus)

Abstract

Manganese (Mn) is an essential heavy metal. However, Mn's nutritional aspects are paralleled by its role as a neurotoxicant upon excessive exposure. In this review, we covered recent advances in identifying mechanisms of Mn uptake and its molecular actions in the brain as well as promising neuroprotective strategies. The authors focused on reporting findings regarding Mn transport mechanisms, Mn effects on cholinergic system, behavioral alterations induced by Mn exposure and studies of neuroprotective strategies against Mn intoxication. We report that exposure to Mn may arise from environmental sources, occupational settings, food, total parenteral nutrition (TPN), methcathinone drug abuse or even genetic factors, such as mutation in the transporter SLC30A10. Accumulation of Mn occurs mainly in the basal ganglia and leads to a syndrome called manganism, whose symptoms of cognitive dysfunction and motor impairment resemble Parkinson's disease (PD). Various neurotransmitter systems may be impaired due to Mn, especially dopaminergic, but also cholinergic and GABAergic. Several proteins have been identified to transport Mn, including divalent metal tranporter-1 (DMT-1), SLC30A10, transferrin and ferroportin and allow its accumulation in the central nervous system. Parallel to identification of Mn neurotoxic properties, neuroprotective strategies have been reported, and these include endogenous antioxidants (for instance, vitamin E), plant extracts (complex mixtures containing polyphenols and non-characterized components), iron chelating agents, precursors of glutathione (GSH), and synthetic compounds that can experimentally afford protection against Mn-induced neurotoxicity.

Original languageEnglish (US)
Article number57
JournalBMC Pharmacology and Toxicology
Volume17
Issue number1
DOIs
StatePublished - Nov 4 2016

Fingerprint

Manganese
Cholinergic Agents
Iron Chelating Agents
Total Parenteral Nutrition
Plant Extracts
Polyphenols
Transferrin
Heavy Metals
Basal Ganglia
Complex Mixtures
Vitamin E
Substance-Related Disorders
Glutathione
Neurotransmitter Agents
Parkinson Disease
Central Nervous System
Antioxidants
Metals
Food

Keywords

  • Acetylcholine
  • Manganese
  • Manganese-transporters
  • Neuroprotection

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

"Manganese-induced neurotoxicity : A review of its behavioral consequences and neuroprotective strategies". / Peres, Tanara V.; Schettinger, Maria Rosa C; Chen, Pan; Carvalho, Fabiano; Avila, Daiana S.; Bowman, Aaron B.; Aschner, Michael.

In: BMC Pharmacology and Toxicology, Vol. 17, No. 1, 57, 04.11.2016.

Research output: Contribution to journalReview article

Peres, Tanara V. ; Schettinger, Maria Rosa C ; Chen, Pan ; Carvalho, Fabiano ; Avila, Daiana S. ; Bowman, Aaron B. ; Aschner, Michael. / "Manganese-induced neurotoxicity : A review of its behavioral consequences and neuroprotective strategies". In: BMC Pharmacology and Toxicology. 2016 ; Vol. 17, No. 1.
@article{191c94df65774195a6257894fc531100,
title = "{"}Manganese-induced neurotoxicity: A review of its behavioral consequences and neuroprotective strategies{"}",
abstract = "Manganese (Mn) is an essential heavy metal. However, Mn's nutritional aspects are paralleled by its role as a neurotoxicant upon excessive exposure. In this review, we covered recent advances in identifying mechanisms of Mn uptake and its molecular actions in the brain as well as promising neuroprotective strategies. The authors focused on reporting findings regarding Mn transport mechanisms, Mn effects on cholinergic system, behavioral alterations induced by Mn exposure and studies of neuroprotective strategies against Mn intoxication. We report that exposure to Mn may arise from environmental sources, occupational settings, food, total parenteral nutrition (TPN), methcathinone drug abuse or even genetic factors, such as mutation in the transporter SLC30A10. Accumulation of Mn occurs mainly in the basal ganglia and leads to a syndrome called manganism, whose symptoms of cognitive dysfunction and motor impairment resemble Parkinson's disease (PD). Various neurotransmitter systems may be impaired due to Mn, especially dopaminergic, but also cholinergic and GABAergic. Several proteins have been identified to transport Mn, including divalent metal tranporter-1 (DMT-1), SLC30A10, transferrin and ferroportin and allow its accumulation in the central nervous system. Parallel to identification of Mn neurotoxic properties, neuroprotective strategies have been reported, and these include endogenous antioxidants (for instance, vitamin E), plant extracts (complex mixtures containing polyphenols and non-characterized components), iron chelating agents, precursors of glutathione (GSH), and synthetic compounds that can experimentally afford protection against Mn-induced neurotoxicity.",
keywords = "Acetylcholine, Manganese, Manganese-transporters, Neuroprotection",
author = "Peres, {Tanara V.} and Schettinger, {Maria Rosa C} and Pan Chen and Fabiano Carvalho and Avila, {Daiana S.} and Bowman, {Aaron B.} and Michael Aschner",
year = "2016",
month = "11",
day = "4",
doi = "10.1186/s40360-016-0099-0",
language = "English (US)",
volume = "17",
journal = "BMC pharmacology & toxicology",
issn = "2050-6511",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - "Manganese-induced neurotoxicity

T2 - A review of its behavioral consequences and neuroprotective strategies"

AU - Peres, Tanara V.

AU - Schettinger, Maria Rosa C

AU - Chen, Pan

AU - Carvalho, Fabiano

AU - Avila, Daiana S.

AU - Bowman, Aaron B.

AU - Aschner, Michael

PY - 2016/11/4

Y1 - 2016/11/4

N2 - Manganese (Mn) is an essential heavy metal. However, Mn's nutritional aspects are paralleled by its role as a neurotoxicant upon excessive exposure. In this review, we covered recent advances in identifying mechanisms of Mn uptake and its molecular actions in the brain as well as promising neuroprotective strategies. The authors focused on reporting findings regarding Mn transport mechanisms, Mn effects on cholinergic system, behavioral alterations induced by Mn exposure and studies of neuroprotective strategies against Mn intoxication. We report that exposure to Mn may arise from environmental sources, occupational settings, food, total parenteral nutrition (TPN), methcathinone drug abuse or even genetic factors, such as mutation in the transporter SLC30A10. Accumulation of Mn occurs mainly in the basal ganglia and leads to a syndrome called manganism, whose symptoms of cognitive dysfunction and motor impairment resemble Parkinson's disease (PD). Various neurotransmitter systems may be impaired due to Mn, especially dopaminergic, but also cholinergic and GABAergic. Several proteins have been identified to transport Mn, including divalent metal tranporter-1 (DMT-1), SLC30A10, transferrin and ferroportin and allow its accumulation in the central nervous system. Parallel to identification of Mn neurotoxic properties, neuroprotective strategies have been reported, and these include endogenous antioxidants (for instance, vitamin E), plant extracts (complex mixtures containing polyphenols and non-characterized components), iron chelating agents, precursors of glutathione (GSH), and synthetic compounds that can experimentally afford protection against Mn-induced neurotoxicity.

AB - Manganese (Mn) is an essential heavy metal. However, Mn's nutritional aspects are paralleled by its role as a neurotoxicant upon excessive exposure. In this review, we covered recent advances in identifying mechanisms of Mn uptake and its molecular actions in the brain as well as promising neuroprotective strategies. The authors focused on reporting findings regarding Mn transport mechanisms, Mn effects on cholinergic system, behavioral alterations induced by Mn exposure and studies of neuroprotective strategies against Mn intoxication. We report that exposure to Mn may arise from environmental sources, occupational settings, food, total parenteral nutrition (TPN), methcathinone drug abuse or even genetic factors, such as mutation in the transporter SLC30A10. Accumulation of Mn occurs mainly in the basal ganglia and leads to a syndrome called manganism, whose symptoms of cognitive dysfunction and motor impairment resemble Parkinson's disease (PD). Various neurotransmitter systems may be impaired due to Mn, especially dopaminergic, but also cholinergic and GABAergic. Several proteins have been identified to transport Mn, including divalent metal tranporter-1 (DMT-1), SLC30A10, transferrin and ferroportin and allow its accumulation in the central nervous system. Parallel to identification of Mn neurotoxic properties, neuroprotective strategies have been reported, and these include endogenous antioxidants (for instance, vitamin E), plant extracts (complex mixtures containing polyphenols and non-characterized components), iron chelating agents, precursors of glutathione (GSH), and synthetic compounds that can experimentally afford protection against Mn-induced neurotoxicity.

KW - Acetylcholine

KW - Manganese

KW - Manganese-transporters

KW - Neuroprotection

UR - http://www.scopus.com/inward/record.url?scp=84994332512&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994332512&partnerID=8YFLogxK

U2 - 10.1186/s40360-016-0099-0

DO - 10.1186/s40360-016-0099-0

M3 - Review article

C2 - 27814772

AN - SCOPUS:84994332512

VL - 17

JO - BMC pharmacology & toxicology

JF - BMC pharmacology & toxicology

SN - 2050-6511

IS - 1

M1 - 57

ER -